Web1 aug. 2012 · Richard Kornbluth and Mariusz Stempniak are employees of Multimeric Biotherapeutics, Inc., La Jolla, CA, which is a company formed to develop these new forms of CD40L, including Acrp30-CD40L (MegaCD40L™) and SP-D-CD40L (UltraCD40L™). Go to: References 1. Clark EA, Ledbetter JA. WebMultimeric Biotherapeutics, Inc. Dr. Richard Kornbluth is an immunologist, physician, and serial entrepreneur. Richard trained at Harvard (A.B.), New York Medical College (M.D.), Columbia University (Ph.D.), and the Scripps Research Institute (postdoc). He was a faculty member at Univ. Calif. San Diego where he worked on HIV...
TEAM - GRI Bio
WebMultimeric Biotherapeutics Inc - Company Profile and News - Bloomberg Markets Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and... Web7 nov. 2011 · Multimeric Biotherapeutics Inc. Headquarters: La Jolla, CA Website: http://www.multimericbio.com... Year Founded: 2008 Status: Archived Historical deals and financings can be found by searching the organization's name in the BCIQ Dealsand FinancingModules. BioCentury Nov 7, 2011 Company News Multimeric … bak baukultur
Nanoparticle-Delivered Multimeric Soluble CD40L DNA …
WebChair at Multimeric Biotherapeutics. Join to edit. About. Marc Herz, PhD is a founder of Multimeric who has extensive experience in vaccine development. He was previously CEO of Pharmexa, Inc. (formerly Epimmune, Inc.), a publicly traded subsidiary of Pharmexa A/S that developed vaccines and cancer immunotherapies. At Pharmexa, he was ... WebMultimeric Biotherapeutics, Inc. University of California, Berkeley Company Website About Recognized executive level scientific and … WebMultimeric Biotherapeutics. Nov 2014 - Present8 years 1 month. Greater San Diego Area. bak baterias